Cancer Leadership Council
 
Home  |  Sitemap  |  Contact Info
 
About CLCWhat's NewPolicy IssuesParticipants' Login

Clinical Trials—Medicare  |  Clinical Trials—Private Insurance  |  Medicare Payment
FDA  |  Cancer Research  |  Stem Cell Research
 
Policy Issues
 
Stem Cell Research
 

PDF versionPrinter-friendly

LETTER TO SENATORS HARKIN AND SPECTER EXPRESSING SUPPORT
FOR FEDERAL FUNDING OF STEM CELL RESEARCH
(April 25, 2000)

April 25, 2000

The Honorable Arlen Specter
711 Hart Senate Office Bldg.
Washington, D.C. 20510

The Honorable Tom Harkin
731 Hart Senate Office Bldg.
Washington, D.C. 20510

Dear Senators Specter and Harkin:

The undersigned organizations, representing individuals with cancer, their families, and their caregivers, are writing to express their support for federal funding and oversight of human pluripotent stem cell research. Stem cell research holds great scientific and medical promise, and it should proceed under appropriate guidelines. We believe federal involvement in stem cell research is critical, not only to ensure that there is adequate funding of this research, but also to guarantee that the research is conducted according to appropriate ethical standards.

In December 1999, the National Institutes of Health (NIH) published "Draft Guidelines for Research Involving Human Pluripotent Stem Cells," which establish standards that achieve appropriate ethical protections while allowing this research to proceed. The guidelines also outline NIH's plan to establish a Human Pluripotent Stem Cell Review Group to oversee stem cell research. This review panel will not only provide information about the conditions under which stem cell research is conducted, but will also collect data about its benefits. NIH's involvement is necessary to assure policymakers and the public that stem cell research is being conducted according to ethical standards.

Stem cell research has the potential to advance our fundamental knowledge of cancer and other serious diseases and to accelerate the development of new therapies for life-threatening illnesses. We strongly support biomedical research, and we advocate policies that create a positive environment for such research.

Sincerely,

Cancer Leadership Council

Alliance for Lung Cancer Advocacy, Support, and Education
American Society of Clinical Oncology
Cancer Care, Inc.
Cancer Research Foundation of America
The Children's Cause, Inc.
Coalition of National Cancer Cooperative Groups
Cure For Lymphoma Foundation
Kidney Cancer Association
National Alliance of Breast Cancer Organizations
National Coalition for Cancer Survivorship
National Prostate Cancer Coalition
North American Brain Tumor Coalition
Oncology Nursing Society
Pancreatic Cancer Action Network
The Susan G. Komen Breast Cancer Foundation
US-TOO International, Inc.
Y-ME National Breast Cancer Organization

Back to Stem Cell Research Index

hr.gif

About CLC  |  What's New  |  Policy Issues  |  Participants' Login
Home  |  Sitemap  |  Contact Info

Copyright © 2001-2002 Cancer Leadership Council. All rights reserved.
Please send comments and suggestions to webmaster@cancerleadership.org.